Therefore, Müller glial BDNF-TrkB signalling is not only involved in neuroprotection, but also in neurogenesis, indicating that TrkB in glia may be a good therapeutic target for neurodegenerative diseases. This evidence concerns the gene NTRK2 and neurodegenerative disease.